"Influenza, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.
| Descriptor ID |
D007251
|
| MeSH Number(s) |
C02.782.620.365 C08.730.310
|
| Concept/Terms |
Influenza, Human- Influenza, Human
- Human Influenzas
- Influenzas, Human
- Influenza
- Influenzas
- Human Flu
- Flu, Human
- Human Influenza
- Influenza in Humans
- Influenza in Human
- Grippe
|
Below are MeSH descriptors whose meaning is more general than "Influenza, Human".
Below are MeSH descriptors whose meaning is more specific than "Influenza, Human".
This graph shows the total number of publications written about "Influenza, Human" by people in this website by year, and whether "Influenza, Human" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 3 | 1 | 4 |
| 1997 | 2 | 1 | 3 |
| 1998 | 2 | 0 | 2 |
| 1999 | 2 | 1 | 3 |
| 2000 | 3 | 2 | 5 |
| 2001 | 1 | 0 | 1 |
| 2002 | 7 | 0 | 7 |
| 2003 | 5 | 1 | 6 |
| 2004 | 9 | 0 | 9 |
| 2005 | 7 | 2 | 9 |
| 2006 | 7 | 1 | 8 |
| 2007 | 7 | 1 | 8 |
| 2008 | 7 | 1 | 8 |
| 2009 | 16 | 3 | 19 |
| 2010 | 17 | 0 | 17 |
| 2011 | 13 | 2 | 15 |
| 2012 | 13 | 1 | 14 |
| 2013 | 13 | 1 | 14 |
| 2014 | 11 | 3 | 14 |
| 2015 | 17 | 2 | 19 |
| 2016 | 18 | 2 | 20 |
| 2017 | 15 | 1 | 16 |
| 2018 | 14 | 6 | 20 |
| 2019 | 27 | 6 | 33 |
| 2020 | 24 | 4 | 28 |
| 2021 | 34 | 2 | 36 |
| 2022 | 35 | 2 | 37 |
| 2023 | 24 | 0 | 24 |
| 2024 | 29 | 1 | 30 |
| 2025 | 22 | 2 | 24 |
To return to the timeline,
click here.
Below are the most recent publications written about "Influenza, Human" by people in Profiles.
-
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024. J Infect Dis. 2025 Oct 15; 232(4):e626-e636.
-
Antiviral Use Among Children Hospitalized With Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance Study. Clin Infect Dis. 2025 Oct 06; 81(3):623-633.
-
Risk of Highly Pathogenic Avian Influenza A/H5N1 Virus in Pediatrics. J Pediatric Infect Dis Soc. 2025 Oct 02; 14(10).
-
Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutations. Sci Adv. 2025 Sep 12; 11(37):eadx3505.
-
Clinical Testing for COVID-19, Influenza, and RSV in Hospitalized Youths, 2016-2024. JAMA Netw Open. 2025 Sep 02; 8(9):e2531499.
-
Clinician Preferences for Oseltamivir Use in Children With Influenza in the Outpatient Setting. Pediatrics. 2025 Sep 01; 156(3).
-
Influenza-Associated Acute Necrotizing Encephalopathy in US Children. JAMA. 2025 08 26; 334(8):692-701.
-
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study. Clin Infect Dis. 2025 Aug 01; 81(1):190-197.
-
Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel. Vaccine. 2025 Aug 13; 61:127361.
-
Pan-H7 influenza human antibody virus neutralization depends on avidity and steric hindrance. JCI Insight. 2025 Jul 08; 10(13).